Mast Therapeutics (MSTX) Tops Q4 EPS by 1c

Mast Therapeutics (NYSE: MSTX) reported Q4 EPS of ($0.05), $0.01 better than the analyst estimate of ($0.06).

For earnings history and earnings-related data on Mast Therapeutics (MSTX) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Algorhythm Holdings (RIME) Tops Q2 EPS by 54c
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c